-
Information-Publications
-
Rna M6a Methylation Regulates Glycolysis of Beige Fat and Contributes to Systemic Metabolic HomeostasisDetails
-
Aptamer-functionalized binary-drug delivery system for synergetic obesity therapyDetails
-
Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variantsDetails
-
Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editingDetails
-
A new class of potent liver injury protective compounds: Structural elucidation, total synthesis and bioactivity studyDetails
-
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibodyDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands